Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-18-020736)

Filing Details

Accession Number:: 0001209191-18-020736
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-03-19 19:22:04
Reporting Period:: 2018-03-19

Accepted Time:: 2018-03-19 19:22:04
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
818033	Heron Therapeutics Inc.	HRTX	Pharmaceutical Preparations (2834)	942875566

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1384243	D Barry Quart	4242 Campus Point Court Suite 200 San Diego CA 92121	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2018-03-19	100,000	$7.20	167,993	No	4	M	Direct
Common Stock	Disposition	2018-03-19	100,000	$29.75	67,993	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (Right to Buy)	Disposition	2018-03-19	100,000	$0.00	100,000	$7.20

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
730,276		2023-05-01	No	4	M	Direct

Footnotes

The stock option exercise and sale of common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan executed in December 2017.
At the date of filing, 542,776 shares of the options granted pursuant to the underlying awards were fully vested and exercisable.